Anna Babayan
Overview
Explore the profile of Anna Babayan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
713
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Babayan A, Ledin E, Lebedeva A, Kuznetsova O, Kravchuk D, Grigoreva T, et al.
Immunotherapy
. 2024 Jul;
16(13):853-858.
PMID: 39041702
Microsatellite instability (MSI) is an important biomarker in cancer. While routine methods can detect MSI in certain tumor types, in other tumor types the results may be incorrect due to...
2.
Rusetsky Y, Meytel I, Mokoyan Z, Fisenko A, Babayan A, Malyavina U
Laryngoscope
. 2021 Jan;
131(8):E2475-E2480.
PMID: 33443298
Objectives/hypothesis: This study aimed to evaluate the olfactory status in children with laboratory confirmed SARS-CoV-2 using subjective and psychophysical methods. Study Design: Prospective clinical cross-sectional study. Methods: This is a...
3.
Babayan A, Neumann M, Herdean A, Shaffer J, Janning M, Kobus F, et al.
Cancers (Basel)
. 2020 May;
12(5).
PMID: 32380788
Background: Among emerging circulating biomarkers, miRNA has the potential to detect lung cancer and follow the course of the disease. However, miRNA analysis deserves further standardization before implementation into clinical...
4.
Liu H, Koch C, Haller A, Joosse S, Kumar R, Vellekoop M, et al.
Adv Biosyst
. 2020 Apr;
4(2):e1900162.
PMID: 32293134
The capture of circulating tumor cells (CTCs) is still a challenging application for microfluidic chips, as these cells are rare and hidden in a huge background of blood cells. Here,...
5.
Gorges K, Wiltfang L, Gorges T, Sartori A, Hildebrandt L, Keller L, et al.
Cancers (Basel)
. 2019 Nov;
11(11).
PMID: 31671846
Despite remarkable progress in melanoma therapy, the exceptional heterogeneity of the disease has prevented the development of reliable companion biomarkers for the prediction or monitoring of therapy responses. Here, we...
6.
Lampignano R, Neumann M, Weber S, Kloten V, Herdean A, Voss T, et al.
Clin Chem
. 2019 Oct;
66(1):149-160.
PMID: 31628139
Background: In cancer patients, circulating cell-free DNA (ccfDNA) can contain tumor-derived DNA (ctDNA), which enables noninvasive diagnosis, real-time monitoring, and treatment susceptibility testing. However, ctDNA fractions are highly variable, which...
7.
Janning M, Kobus F, Babayan A, Wikman H, Velthaus J, Bergmann S, et al.
Cancers (Basel)
. 2019 Jun;
11(6).
PMID: 31212989
Circulating tumor cells (CTCs) hold great potential to answer key questions of how non-small cell lung cancer (NSCLC) evolves and develops resistance upon anti-PD-1/PD-L1 treatment. Currently, their clinical utility in...
8.
Ricklefs F, Maire C, Reimer R, Duhrsen L, Kolbe K, Holz M, et al.
J Extracell Vesicles
. 2019 Apr;
8(1):1588555.
PMID: 30949309
Cells release heterogeneous nano-sized vesicles either as exosomes, being derived from endosomal compartments, or through budding from the plasma membrane as so-called microvesicles, commonly referred to as extracellular vesicles (EVs)....
9.
Soler A, Cayrefourcq L, Mazard T, Babayan A, Lamy P, Assou S, et al.
Sci Rep
. 2018 Oct;
8(1):15931.
PMID: 30374140
Circulating tumor cells (CTCs) are important clinical indicators for prognosis and treatment efficacy. However, CTC investigation is hampered by their low number, making the establishment of permanent CTC lines very...
10.
Joosse S, Souche F, Babayan A, Gasch C, Kerkhoven R, Ramos J, et al.
Clin Chem
. 2018 Jul;
64(10):1505-1512.
PMID: 30030273
Background: Genomic information can help to identify colorectal tumors with high and low metastatic potential, thereby improving prediction of benefit of local and/or systemic treatment. Here we investigated chromosomal aberrations...